Ignite Creation Date:
2024-05-06 @ 1:54 PM
Last Modification Date:
2024-10-26 @ 1:22 PM
Study NCT ID:
NCT04158310
Status:
UNKNOWN
Last Update Posted:
2019-11-08
First Post:
2019-10-30
Brief Title:
Evaluation the Clinical Value of Xiyanping Injection in the Treatment of Community-acquired Pneumonia in Children
Sponsor:
Jiangxi Qingfeng Pharmaceutical Co Ltd
Organization:
Jiangxi Qingfeng Pharmaceutical Co Ltd
Study Overview
Official Title:
Evaluation of Clinical Value and Safety of Xiyanping Injection in the Treatment of Community-acquired Pneumonia in Children Based on Real-world Clinical Data
Status:
UNKNOWN
Status Verified Date:
2019-10
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
In order to verify the clinical value and safety of Xiyanping injection in children with CAP we intend to carry out this multi-center large-sample non-intervention clinical research through more rigorous and scientific design Considering the current status of clinical research in children in Chinaresearch use real-world research methods
Detailed Description:
This is an real world study of efficacy and safety of intravenous injection of Xiyanping injection in pediatric subjects with CAPThe purpose to determine the clinical value and influencing factors of Xiyanping injection in the treatment of community-acquired pneumonia in children based on real-world clinical data The starting point for the study was the time at which the patient started treatment with Xiyanping injection or using a conventional treatment regimen the end of follow-up was the date of the last visit to the patient and if the patient had a disease progression or transfer the date of the occurrence was the end At the same time baseline demographic characteristics gender date of birth type of medical insurance etc therapeutic drugs during the follow-up period dose and time of use laboratory indicators such as white blood cells C-reactive protein etc and examination time were collected
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None